Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2019	Mar. 25, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 1,649,605	$ 1,359,535
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	243,873	241,276
Deferred income taxes	(75,105)	(209,214)
Equity-based compensation expense	142,389	125,002
Amortization of note discounts and issuance costs	5,137	13,469
Impairment of investment	0	42,456
Other, net	(646)	23,327
Changes in operating assets and liabilities	330,273	341,538
Net cash provided by operating activities	2,295,526	1,937,389
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets	(237,543)	(193,814)
Business acquisition, net of cash acquired	0	(115,697)
Purchases of available-for-sale securities	(1,975,688)	(2,377,459)
Maturities of available-for-sales securities	395,569	549,539
Sales of available-for-sale securities	809,379	3,639,331
Other, net	(5,288)	(14,358)
Net cash (used for) provided by investing activities	(1,013,571)	1,487,542
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on debt	(116,496)	(577,415)
Net (repayments) proceeds from issuance of commercial paper	(61,754)	997,971
Proceeds from borrowings on revolving credit facility	0	750,000
Repayments of borrowings on revolving credit facility	0	(750,000)
Proceeds from issuance of long-term debt, net of issuance costs	2,476,720	0
Treasury stock purchases	(2,672,051)	(1,346,940)
Dividends paid	(513,475)	(225,604)
Reissuance of treasury stock related to employee stock purchase plan	32,920	34,057
Proceeds from issuance of common stock	5,119	6,632
Other, net	(13,207)	11
Net cash used for financing activities	(862,224)	(1,111,288)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(904)	8,200
Net increase in cash, cash equivalents, and restricted cash	418,827	2,321,843
Cash, cash equivalents, and restricted cash at beginning of period	4,768,558	2,633,739
Cash, cash equivalents, and restricted cash at end of period	5,187,385	4,955,582
Schedule of non-cash transactions:
Accrued payables for stock repurchases	1,637	2,165
Accrued payables for capital expenditures	27,283	32,610
Transfers of inventory to property and equipment, net	42,519	38,878
Reconciliation of cash, cash equivalents, and restricted cash
Total Cash, cash equivalents, and restricted cash	$ 4,768,558	$ 2,633,739